“Executing states are going to great lengths to hide these purchases from taxpayers and defense attorneys and the pharmaceutical companies whose controls they’re violating — and they keep getting caught,” said Matt Wells, the deputy director of Reprieve US.
“When state after state is spending hundreds of thousands of dollars on the black market to acquire drugs they cannot legitimately source, we’re talking about a system that is broken beyond repair.”
Read the full story here